Blad- der cancer diagnosis and recurrence prognosis: com- parison of markers with emphasis on survivin. Clin Chim Acta 2006;368:20 ^ 32.Schultz J,Witjes JA,Swinkels DW et al.Bladder cancer diagnosis and recurrence prognosis: Comparison of markers with emphasis on survivin. Clinica Chimica Acta ...
A bladder cancer diagnosis and/or prognosis kit based on the use of a set of probes suitable for the detection and quantification of the expression pattern of said genes is also contemplated.Antonio Alcaraz AsensioLourdes Mengual BrichsMoises Burset Albareda...
The presence of lymphatic metastasis is associated with markedly worse prognosis in patients with bladder cancer, although surgical resection and chemotherapy can still provide long-term survival for selected patients. The prognostic stratification of patients with positive lymph nodes has been broadly discu...
Bladder cancer (BCa) is one of the most common urinary malignancies and there are around ten thousand newly diagnosed BCa per year worldwide1. Approximately 3/4 BCa are non- muscle-invasive bladder cancer (NMIBC) at the initial time of being diagnosed2. Treatment strategies for NMIBC include ...
Genetic makeup, race, andfamily history.Bladder cancer is most common in white men over age 55. If you or someone in your immediate family (parents or siblings) has hadcancerof the bladder or the urinary tract before, you’re more likely to get it. ...
Tumour immune regulation has attracted widespread attention, and long noncoding RNAs (lncRNAs) play an important role in this process. Therefore, we evaluated patient prognosis by exploring the relationship between bladder cancer (BLCA) and immune-related lncRNAs (IRlncRNAs). Transcriptome data and imm...
Bladder cancer is an excellent model for applying biomarkers to clinical detection and prognosis because of its variable natural history and the ease with which specimens can be obtained. Bladder tumor marker development initially focused on detection. Cytology, the oldest urinary biomarker for bladder ...
Purpose: We have previously found ADAM12, a disintegrin and metalloprotease, to be an interesting biomarker for breast cancer.The purpose of this study was to determine the gene and protein expression profiles of ADAM12 in different grades and stages of bladder cancer. Experimental Design: ADAM12...
Advanced prostate and bladder cancer are two outstanding unmet medical needs for urological oncologists. The high prevalence of these tumours, lack of effective biomarkers and limited effective treatment options highlight the importance of basic research in these diseases. Galectins are a family of β...
Advanced age is also associated with elevated markers of chronic inflammation and perturbations in gut and urinary tract microbiota. One reason for the increased incidence and mortality of bladder cancer in the elderly might be that age-associated changes in multiple microbiomes induce systemic ...